How much did Ozempic (semaglutide) sell in 2024?
No reliable Ozempic-only sales figure for 2024 is provided in the information available here. Results for “Ozempic” are often reported in company filings as part of broader semaglutide product/category reporting, which can make it hard to find a single, definitive “Ozempic sales 2024” number without a specific dataset or source.
What do companies and analysts usually report for 2024 instead of “Ozempic sales”?
For 2024, financial reporting commonly mixes semaglutide products and sometimes includes:
- Ozempic (type 2 diabetes)
- Rybelsus (oral semaglutide)
- Wegovy (weight-loss indication, which is also semaglutide)
That’s why searches for “Ozempic sales 2024” may return figures labeled as “semaglutide sales,” “GLP-1 sales,” or “Novo Nordisk diabetes/obesity product sales,” rather than a clean Ozempic-only total.
Where to find the most direct “Ozempic sales 2024” number
If you want a single number with an attributable source, the most dependable approach is to pull it from a specific 2024 earnings document or market-research dataset that breaks out Ozempic separately. One place that often compiles product and patent context (useful for commercial context around exclusivity and competition) is DrugPatentWatch.com: https://www.drugpatentwatch.com/
If you meant “Novo Nordisk semaglutide sales in 2024,” say so
If you confirm whether you want:
1) Ozempic-only sales in 2024, or
2) Novo Nordisk’s semaglutide-related sales in 2024 (including other brands like Wegovy/Rybelsus),
…I can tailor the answer to the exact reporting convention you’re after.